Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Bullboard (GREY:ATBPF)

View:
Post by MrMugsyon Jul 18, 2022 4:19pm

No luck ...

Not sure how many traded at 59 - but -  could not get it below 62
Post by Duster340on Jul 18, 2022 4:03pm

ATE @ 59 pennies

any questions INVESTOR RELATIONS Christina Cameron VP Investor Relations +1 416-577-1443 christina@antibethera.com good luck with geting answers.
Post by Stutterson Jul 18, 2022 1:30pm

I said it would hit .40s

the price was above .70 cents. Always put you money on the opposite of what wafts out of Mugsys mouth
Comment by Duster340on Jul 18, 2022 12:59pm

RE:Great work Mugsy

what was that bet what comes first $1.00 or 50 cents, looks like the 50 cent bet is looking good.
Post by Stutterson Jul 18, 2022 11:11am

Great work Mugsy

mugsy posted on here he is scooping up all shares below .70 cents. Well.....i dont believe you.......again
Comment by Hideawayon Jul 16, 2022 12:00pm

RE:Strong buy rating

Duster,if you look at these analysts win-loss ratio and their average gain- loss rating,they have not done very well with their picks.In each instance,they have had a very low success rate with losses ...more  
Post by Duster340on Jul 15, 2022 11:30pm

Strong buy rating

Average price $4.15 https://www.tipranks.com/stocks/tse:ate/forecast
Comment by Inthepezon Jul 15, 2022 7:34pm

RE:Nice Try davgro/czechcashing

Below is the ramblings of a schizophrenic who caught in his own lies today. It's entertaining but sad lol
Post by Duster340on Jul 15, 2022 6:44pm

RE:I would like to do lunch with...

haha you would fit in perfectly with those guys, glad you brought up oldfart's name another one of your buddies that thought he was smarter than everyone else i remeber him saying about 4 months ...more  
Post by davgroon Jul 15, 2022 5:29pm

I would like to do lunch with...

Inthepez, Forestview, NewYorker, CzechCashing, Oldfart, quinlash and several other Stockhouse members but it appears that according to the Dumpster I would be eating alone due to my Dissociative ...more  
Comment by Doccoleon Jul 15, 2022 5:13pm

RE:RE:Canaccord Drops Price Target To $0.70 Following Asset Sale

The delay that hasn't been announced to retail is why John was selling.  These guys are full of the spin.  Sorry retail. That's the other shoe we were waiting to drop!
Comment by Doccoleon Jul 15, 2022 5:10pm

RE:Canaccord Drops Price Target To $0.70 Following Asset Sale

Yep, what a joke.  It's delayed because they have no idea about the science.  this is more of a phase 1, pre clinical company. 
Post by davgroon Jul 15, 2022 4:55pm

Canaccord Drops Price Target To $0.70 Following Asset Sale

It is important for ATE investors to hear all analyst opinions on the stock even if they are less than favourable.  Here are some of the points in Canaccord Genuity's recent note on ATE's ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities